US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jul 2, 2013 (13 years ago)

Pseudoephedrine HCL

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling: Label Mixup; PSEUDOEPHEDRINE HCL, Tablet, 30 mg may be potentially mislabeled as D-ALPHA TOCOPHERYL ACETATE, Capsule, 400 units, NDC 49348041010, Pedigree: AD52993_28, EXP: 5/20/2014.

What was recalled

PSEUDOEPHEDRINE HCL, Tablet, 30 mg, Rx in Oregon, Distributed by: AidaPak Service, LLC, NDC 00904505360

Recalling firm
Aidapak Services, LLC
Origin
WA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-469-2014

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Ephedrine recalls

See all
Class II · Moderate risk Terminated

ePHEDrine in 0.9% sodium chloride

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc NDC 71286-6004-1 D-0003-2024
Class II · Moderate risk Terminated

ePHEDrine in 0.9% sodium chloride

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc NDC 71286-6004-1 D-1073-2023
Class II · Moderate risk Ongoing

Ephedrine Sulfate Injection

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0802-2023
Class III · Low risk Terminated

Allergy Relief D

Reason Failed dissolution specifications

Dr. Reddy's Laboratories, Inc. NDC 49032-273-20 D-0073-2023